BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 27614622)

  • 21. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
    Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
    Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.
    Lee HY; Yeh HC; Wu WJ; He JS; Huang CN; Ke HL; Li WM; Li CF; Li CC
    World J Surg Oncol; 2018 Jul; 16(1):135. PubMed ID: 29986730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.
    Chung Y; Lee DH; Lee M; Kim H; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    Investig Clin Urol; 2020 Mar; 61(2):158-165. PubMed ID: 32158966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
    Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
    Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Preoperative Bacteriuria and Pyuria on Intravesical Recurrence in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
    Fukushima H; Kobayashi M; Kawano K; Morimoto S
    In Vivo; 2017; 31(6):1215-1220. PubMed ID: 29102949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).
    Katims AB; Say R; Derweesh I; Uzzo R; Minervini A; Wu Z; Abdollah F; Sundaram C; Ferro M; Rha K; Mottrie A; Rosiello G; Simone G; Eun DD; Reese A; Kidd LC; Porter J; Bhattu AS; Gonzalgo ML; Margulis V; Marcus J; Danno A; Meagher M; Tellini R; Mari A; Veccia A; Ghoreifi A; Autorino R; Djaladat H; Mehrazin R
    J Urol; 2021 Sep; 206(3):568-576. PubMed ID: 33881931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
    Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
    Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.
    Seisen T; Granger B; Colin P; Léon P; Utard G; Renard-Penna R; Compérat E; Mozer P; Cussenot O; Shariat SF; Rouprêt M
    Eur Urol; 2015 Jun; 67(6):1122-1133. PubMed ID: 25488681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.
    Xylinas E; Colin P; Audenet F; Phe V; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Polguer T; Ruffion A; Valeri A; Rozet F; Long JA; Zerbib M; Rouprêt M
    World J Urol; 2013 Feb; 31(1):61-8. PubMed ID: 23053211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
    Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
    Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Increased the Risk of Intravesical Recurrence.
    Tan P; Xie N; Yang L; Liu L; Tang Z; Wei Q
    Urol Int; 2018; 100(1):92-99. PubMed ID: 29224014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
    Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
    Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
    Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S
    Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.
    Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Khalil D; Kapur P; Shariat SF; Raj GV; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):54.e19-26. PubMed ID: 24360665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma.
    Tan P; Xu H; Liu L; Ai J; Xu H; Jiang Y; Zhang X; Yang L; Wei Q
    Clin Chim Acta; 2018 Oct; 485():26-32. PubMed ID: 29908941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.